Our results suggest that LILRB4, which is upregulated on lung IMs in both human COPD patients and a mouse elastase-induced emphysema model, has a protective effect against the formation of emphysematous lesions through the attenuation of MMP-12 production, mainly by IMs. This evidence concerns the gene MMP12 and pulmonary emphysema.